Dr. Manyi Wei gained his B.S. degree at China Pharmaceutical University in Nanjing. Subsequently, he completed his Ph.D. training in Cell Biology at the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. During his Ph.D. research, Dr. Wei focused on the regulatory role of long non-coding RNA in gene expression and its impact on neuronal function. Dr. Wei has always nurtured a particular interest in understanding and developing novel treatment for leukemia. After his Ph.D. training, Dr. Wei joined the laboratory of Dr. Stephanie Halene at Yale Cancer Center and Yale University School of Medicine. He immediately began exciting work on RNA modifications and their functions in the initiation and progression of acute myeloid leukemia and myelodysplastic syndromes and importantly on novel therapeutic approaches exploiting cell intrinsic and extrinsic effects of targeted inhibitors of RNA methylation. His goal is to contribute to the cure of leukemia.